24 May 2013
Keywords: morphosys/bayer, extend, accord, upto, yrs, german, antibody
Article | 12 December 2005
German antibody developer MorphoSys AG has extended its collaboration with German drug major Bayer by another five years, with a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 2005
12 December 2005
23 May 2013
© 2013 thepharmaletter.com